Friday, May 31, 2019

Lupin#39;s Goa facility may face regulatory action, says USFDA

Lupin#39;s Goa facility may face regulatory action, says USFDA The company has received a letter from the US Food and Drug Administration (USFDA) classifying the inspection conducted at its Goa facility between January 28 to February 8 as Official Action Indicated (OAI), Lupin said in a regulatory filing.

from Moneycontrol Business News http://bit.ly/2Z0UEHU
at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Wipro guides for revenue of (-) 1.5% to 0.5% in Q1FY25

CFO Aparna Iyer said it is a tough macroeconomic environment and clients are going through a very challenging time. from Moneycontrol Bus...